Vasodilatory factors in treatment of older men with symptomatic benign prostatic hyperplasia.
Kaplan
Steven A
SA
Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA. sk46@columbia.edu
Neutel
Joel
J
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D000367:Age Factors; D000368:Aged; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy*; D014664:Vasodilation / Q000187:drug effects*
D000317:Adrenergic alpha-Antagonists; D015106:3',5'-Cyclic-GMP Phosphodiesterases